249 related articles for article (PubMed ID: 26541439)
1. TGR5 and Immunometabolism: Insights from Physiology and Pharmacology.
Perino A; Schoonjans K
Trends Pharmacol Sci; 2015 Dec; 36(12):847-857. PubMed ID: 26541439
[TBL] [Abstract][Full Text] [Related]
2. The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.
Stepanov V; Stankov K; Mikov M
J Recept Signal Transduct Res; 2013 Aug; 33(4):213-23. PubMed ID: 23782454
[TBL] [Abstract][Full Text] [Related]
3. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
Tiwari A; Maiti P
Drug Discov Today; 2009 May; 14(9-10):523-30. PubMed ID: 19429513
[TBL] [Abstract][Full Text] [Related]
4. TGR5 in inflammation and cardiovascular disease.
Pols TW
Biochem Soc Trans; 2014 Apr; 42(2):244-9. PubMed ID: 24646225
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of the bile acid receptor TGR5 in metabolism.
van Nierop FS; Scheltema MJ; Eggink HM; Pols TW; Sonne DP; Knop FK; Soeters MR
Lancet Diabetes Endocrinol; 2017 Mar; 5(3):224-233. PubMed ID: 27639537
[TBL] [Abstract][Full Text] [Related]
6. Role of the G Protein-Coupled Bile Acid Receptor TGR5 in Liver Damage.
Reich M; Klindt C; Deutschmann K; Spomer L; Häussinger D; Keitel V
Dig Dis; 2017; 35(3):235-240. PubMed ID: 28249265
[TBL] [Abstract][Full Text] [Related]
7. Bile acid receptors and the kidney.
Herman-Edelstein M; Weinstein T; Levi M
Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):56-62. PubMed ID: 29045336
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of the bile acid receptor TGR5 in Kupffer cells.
Keitel V; Donner M; Winandy S; Kubitz R; Häussinger D
Biochem Biophys Res Commun; 2008 Jul; 372(1):78-84. PubMed ID: 18468513
[TBL] [Abstract][Full Text] [Related]
9. The TGR5 receptor mediates bile acid-induced itch and analgesia.
Alemi F; Kwon E; Poole DP; Lieu T; Lyo V; Cattaruzza F; Cevikbas F; Steinhoff M; Nassini R; Materazzi S; Guerrero-Alba R; Valdez-Morales E; Cottrell GS; Schoonjans K; Geppetti P; Vanner SJ; Bunnett NW; Corvera CU
J Clin Invest; 2013 Apr; 123(4):1513-30. PubMed ID: 23524965
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of bile acid receptor agonists in pulmonary disease models.
Comeglio P; Morelli A; Adorini L; Maggi M; Vignozzi L
Expert Opin Investig Drugs; 2017 Nov; 26(11):1215-1228. PubMed ID: 28949776
[TBL] [Abstract][Full Text] [Related]
11. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells.
Keitel V; Reinehr R; Gatsios P; Rupprecht C; Görg B; Selbach O; Häussinger D; Kubitz R
Hepatology; 2007 Mar; 45(3):695-704. PubMed ID: 17326144
[TBL] [Abstract][Full Text] [Related]
12. Activation of the bile acid receptor TGR5 enhances LPS-induced inflammatory responses in a human monocytic cell line.
Mobraten K; Haugbro T; Karlstrom E; Kleiveland CR; Lea T
J Recept Signal Transduct Res; 2015; 35(5):402-9. PubMed ID: 25418122
[TBL] [Abstract][Full Text] [Related]
13. TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells.
Yanguas-Casás N; Barreda-Manso MA; Nieto-Sampedro M; Romero-Ramírez L
J Cell Physiol; 2017 Aug; 232(8):2231-2245. PubMed ID: 27987324
[TBL] [Abstract][Full Text] [Related]
14. TGR5: a novel target for weight maintenance and glucose metabolism.
Chen X; Lou G; Meng Z; Huang W
Exp Diabetes Res; 2011; 2011():853501. PubMed ID: 21754919
[TBL] [Abstract][Full Text] [Related]
15. Effect of maternal cholestasis on TGR5 expression in human and rat placenta at term.
Keitel V; Spomer L; Marin JJ; Williamson C; Geenes V; Kubitz R; Häussinger D; Macias RI
Placenta; 2013 Sep; 34(9):810-6. PubMed ID: 23849932
[TBL] [Abstract][Full Text] [Related]
16. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
[TBL] [Abstract][Full Text] [Related]
17. Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors.
Keitel V; Stindt J; Häussinger D
Handb Exp Pharmacol; 2019; 256():19-49. PubMed ID: 31302759
[TBL] [Abstract][Full Text] [Related]
18. G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype.
Högenauer K; Arista L; Schmiedeberg N; Werner G; Jaksche H; Bouhelal R; Nguyen DG; Bhat BG; Raad L; Rauld C; Carballido JM
J Med Chem; 2014 Dec; 57(24):10343-54. PubMed ID: 25411721
[TBL] [Abstract][Full Text] [Related]
19. The bile acid receptor, TGR5, regulates basal and cholinergic-induced secretory responses in rat colon.
Ward JB; Mroz MS; Keely SJ
Neurogastroenterol Motil; 2013 Aug; 25(8):708-11. PubMed ID: 23634890
[TBL] [Abstract][Full Text] [Related]
20. Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction.
Leonhardt J; Haider RS; Sponholz C; Leonhardt S; Drube J; Spengler K; Mihaylov D; Neugebauer S; Kiehntopf M; Lambert NA; Kortgen A; Bruns T; Tacke F; Hoffmann C; Bauer M; Heller R
Cell Mol Gastroenterol Hepatol; 2021; 12(1):25-40. PubMed ID: 33545429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
